tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Balance Sheet

Compare
839 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q4 2025 were $776.22M, an increase of 84.41% from the previous quarter. IMVT total liabilities were $68.78M for the fiscal quarter, a 0.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Assets
$ 776.22M$ 666.37M$ 405.84M$ 515.56M$ 412.49M
Total Liabilities
$ 68.78M$ 48.61M$ 43.34M$ 45.74M$ 21.01M
Total Equity Gross Minority
$ 707.45M$ 617.76M$ 362.49M$ 469.82M$ 391.48M
Other Metrics
Currency in USD

Immunovant Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis